A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians, and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. In the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. The patients we serve annually comprise approximately one-third of the adult population of the United States, and over a three-year period, we serve approximately one-half of the adult population of the United States. We estimate that annually we serve approximately half of the physicians and half of the hospitals in the United States.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 11.0B | 11.0B | 9.9B | 9.3B | 9.9B | 10.8B |
| Net Income | 992M | 992M | 871M | 854M | 946M | 2.0B |
| EPS | $8.75 | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 |
| Free Cash Flow | 1.4B | 1.4B | 909M | 864M | 1.3B | 1.8B |
| ROIC | 8.7% | 9.2% | 8.3% | 9.3% | 11.4% | 19.6% |
| Gross Margin | 33.2% | 33.2% | 32.9% | 33.0% | 34.7% | 39.0% |
| Debt/Equity | 0.96 | 0.96 | 1.01 | 0.90 | 0.78 | 0.72 |
| Dividends/Share | $3.11 | $3.11 | $2.92 | $2.75 | $2.57 | $2.41 |
| Operating Income | 1.6B | 1.6B | 1.3B | 1.3B | 1.4B | 2.4B |
| Operating Margin | 14.1% | 14.1% | 13.6% | 13.6% | 14.4% | 22.1% |
| ROE | 13.8% | 14.2% | 12.9% | 13.5% | 16.1% | 31.0% |
| Shares Outstanding | 113M | 113M | 113M | 114M | 119M | 128M |
QUEST DIAGNOSTICS INC passes 4 of 9 quality checks, suggesting mixed fundamentals.
QUEST DIAGNOSTICS INC trades at 22.0x trailing earnings, compared to its 15-year median P/E of 16.1x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 15.6x vs a median of 13.7x. The company's 5-year average ROIC is 11.5% with a gross margin of 34.6%. Total shareholder yield (dividends + buybacks) is 3.7%. At current prices, the estimated annualized return to fair value is +3.8%.
QUEST DIAGNOSTICS INC (DGX) has a current P/E ratio of 22.0, compared to its historical median P/E of 16.1. The stock is currently considered Expensive based on its historical valuation range.
QUEST DIAGNOSTICS INC (DGX) has a 5-year average return on invested capital (ROIC) of 11.5%. This indicates solid capital allocation.
QUEST DIAGNOSTICS INC (DGX) has a market capitalization of $21.9B. It is classified as a large-cap stock.
Yes, QUEST DIAGNOSTICS INC (DGX) pays a dividend with a trailing twelve-month yield of 1.61%. The company also returns capital through share buybacks, with a buyback yield of 2.06%.
Based on historical P/E analysis, QUEST DIAGNOSTICS INC (DGX) appears expensive. The current P/E of 22.0 is 37% above its historical median of 16.1. The estimated fair value CAGR (P/E method) is 2.1%.
QUEST DIAGNOSTICS INC (DGX) operates in the Services-Medical Laboratories industry, within the Healthcare sector.
QUEST DIAGNOSTICS INC (DGX) reported annual revenue of $11.0 billion in its most recent fiscal year, based on SEC EDGAR filings.
QUEST DIAGNOSTICS INC (DGX) has a net profit margin of 9.0%. This is a modest margin.
QUEST DIAGNOSTICS INC (DGX) generated $1.4 billion in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
QUEST DIAGNOSTICS INC (DGX) has a debt-to-equity ratio of 0.96. This indicates moderate leverage.
QUEST DIAGNOSTICS INC (DGX) reported earnings per share (EPS) of $8.75 in its most recent fiscal year.
QUEST DIAGNOSTICS INC (DGX) has a return on equity (ROE) of 14.2%. This indicates moderate shareholder returns.
QUEST DIAGNOSTICS INC (DGX) has a 5-year average gross margin of 34.6%. This indicates decent pricing power.
The Ledger Terminal provides 19 years of financial data for QUEST DIAGNOSTICS INC (DGX), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
QUEST DIAGNOSTICS INC (DGX) has a book value per share of $63.24, based on its most recent annual SEC filing.
No recent press releases.